Clinical Trials Logo

Clinical Trial Summary

To assess the efficacy and safety of local application of intraoperative mitomycin C (MMC) at osteotomy site in endoscopic dacryocystorhinostomy(EN-DCR).


Clinical Trial Description

Mitomycin C (MMC) is an antineoplastic agent that inhibits the synthesis of DNA, cellular RNA, and protein by inhibiting the synthesis of collagen by fibroblasts. MMC was originally used as a systemic chemotherapeutic agent, it has been widely used in ophthalmic practice both intraoperatively and postoperatively for prevention of pterygium recurrence, enhancing the success rate of glaucoma filtration surgery. Recently, use of MMC has been described in lacrimal drainage surgery. It is postulated that adjunctive use of MMC over the osteotomy site in endoscopic dacryocystorhinostomy(EN-DCR)surgery could inhibit scarring and granulation tissue formation around the osteotomy site or common canaliculus and enhance the success of EN-DCR surgery.

Many controlled trials have investigated adjunctive MMC for primary or revision EN-DCR to augment the surgical success rate, but the results are not completely consistent. To the best of our knowledge, there was no meta-analysis on comparison of success rate of EN-DCR with MMC (MMC group) and endoscopic dacryocystorhinostomy without MMC (control group). Therefore, the aim of this study was to undertake systematic review and meta-analysis to evaluate the efficacy of intraoperative MMC application in EN-DCR surgery and help ophthalmologists to determine whether it is a useful adjuvant in EN-DCR surgery. ;


Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01772277
Study type Observational
Source Wenzhou Medical University
Contact
Status Completed
Phase N/A
Start date December 2012
Completion date February 2014

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04833452 - Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR N/A
Completed NCT00349297 - The Microbiological Spectrum in Acute Dacryocystitis N/A
Recruiting NCT05663684 - Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain? Phase 4
Terminated NCT04229771 - Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain? Phase 4
Recruiting NCT03216642 - The Study of Bacteriology and Pathogen Drug Sensitivity of Chronic Dacryocystitis N/A
Completed NCT00706251 - Follow up of Nasolacrimal Intubation in Adults N/A
Completed NCT00008541 - Evaluation and Treatment of Patients With Corneal and External Diseases N/A
Completed NCT05455944 - Analgesic Efficacy of Pre-operative Oral Pregabalin in Dacryocystorhinostomy Surgery N/A